Bluebird Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.23M Sell
1,863
-127
-6% -$130K 1.94% 15
2026
Q1
$1.83M Sell
1,990
-8
-0.4% -$8.11K 1.87% 19
2025
Q4
$2.15M Buy
+1,998
New +$1.91M 2.01% 17

Other funds holding LLY

Bluebird Wealth Management's LLY Position: Q2 2026 in Review

Bluebird Wealth Management reduced its Eli Lilly (LLY) stake by 6.4% in Q2 2026, selling an estimated $130K and leaving 1,863 shares worth $2.23M. The position accounts for 1.94% of the portfolio, ranked #15.

Bluebird Wealth Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bluebird Wealth Management held 1,863 shares of Eli Lilly worth $2.23M as of Q2 2026.
  • Bluebird Wealth Management sold 127 Eli Lilly shares in Q2 2026, an estimated $130K.
  • Eli Lilly made up 1.94% of Bluebird Wealth Management's portfolio in Q2 2026, its #15 holding.
  • Bluebird Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bluebird Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.